StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
General Electric (GE) to Sell BioPharma Business to Danaher (DHR) for $21.4 Billion
February 25, 2019 7:00 AM
GE (NYSE: GE) announced a definitive agreement to sell its BioPharma business to Danaher Corporation (NYSE: DHR) (“Danaher”) for a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
Hot Corp. News
Hot M&A
Management Comments
Mergers and Acquisitions
Next Articles
Danaher (DHR) Prices 11M Share Common Offering at $123/Sh & Prices Mandatory Convertible Preferred Share Offering
February 27, 2019 5:52 AM
Danaher (DHR) PT Raised to $125 at Baird
February 26, 2019 9:15 AM
Danaher (DHR) Announces Proposed $1.35B Common Share Offering; Announces Concurrent $1.35B Mandatory Convertible Preferred Share Offering
February 26, 2019 5:45 AM
General Electric (GE) Adds to Gains Following BioPharma Deal, Up 18%
February 25, 2019 8:09 AM
General Electric (GE) Jumps 7% on BioPharma Sale
February 25, 2019 7:13 AM
GE to Sell BioPharma Business to Danaher for $21.4 Billion
February 25, 2019 7:00 AM
